Literature DB >> 3058038

Differential energetic metabolism during Trypanosoma cruzi differentiation. I. Citrate synthase, NADP-isocitrate dehydrogenase, and succinate dehydrogenase.

F J Adroher1, A Osuna, J A Lupiañez.   

Abstract

The activities of the mitochondrial enzymes citrate synthase (citrate oxaloacetatelyase, EC 4.1.3.7), NADP-linked isocitrate dehydrogenase (threo-Ds-isocitrate:NADP+ oxidoreductase (decarboxylating), EC 1.1.1.42), and succinate dehydrogenase (succinate: FAD oxidoreductase, EC 1.3.99.1) as well as their kinetic behavior in the two developmental forms of Trypanosoma cruzi at insect vector stage, epimastigotes and infective metacyclic trypomastigotes, were studied. The results presented in this work clearly demonstrate a higher mitochondrial metabolism in the metacyclic forms as is shown by the extraordinary enhanced activities of metacyclic citrate synthase, isocitrate dehydrogenase, and succinate dehydrogenase. In epimastigotes, the specific activities of citrate synthase at variable concentrations of oxalacetate and acetyl-CoA were 24.6 and 26.6 mU/mg of protein, respectively, and the Michaelis constants were 7.88 and 6.84 microM for both substrates. The metacyclic enzyme exhibited the following kinetic parameters: a specific activity of 228.4 mU/mg and Km of 3.18 microM for oxalacetate and 248.5 mU/mg and 2.75 microM, respectively, for acetyl-CoA. NADP-linked isocitrate dehydrogenase specific activities for epimastigotes and metacyclics were 110.2 and 210.3 mU/mg, whereas the apparent Km's were 47.9 and 12.5 microM, respectively. No activity for the NAD-dependent isozyme was found in any form of T. cruzi differentiation. The particulated succinate dehydrogenase showed specific activities of 8.2 and 39.1 mU/mg for epimastigotes and metacyclic trypomastigotes, respectively, although no significant changes in the Km (0.46 and 0.48 mM) were found. The cellular role and the molecular mechanism that probably take place during this significant shift in the mitochondrial metabolism during the T. cruzi differentiation have been discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3058038     DOI: 10.1016/0003-9861(88)90030-6

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  12 in total

1.  Farnesyl diphosphate synthase localizes to the cytoplasm of Trypanosoma cruzi and T. brucei.

Authors:  Marcela Ferella; Zhu-Hong Li; Björn Andersson; Roberto Docampo
Journal:  Exp Parasitol       Date:  2008-03-13       Impact factor: 2.011

2.  A comparative assessment of mitochondrial function in epimastigotes and bloodstream trypomastigotes of Trypanosoma cruzi.

Authors:  Renata L S Gonçalves; Rubem F S Menna Barreto; Carla R Polycarpo; Fernanda R Gadelha; Solange L Castro; Marcus F Oliveira
Journal:  J Bioenerg Biomembr       Date:  2011-11-12       Impact factor: 2.945

3.  Differential energetic metabolism during Trypanosoma cruzi differentiation. II. Hexokinase, phosphofructokinase and pyruvate kinase.

Authors:  F J Adroher; A Osuna; J A Lupiáñez
Journal:  Mol Cell Biochem       Date:  1990-04-18       Impact factor: 3.396

4.  Differential protein expression in Spirometra erinacei according to its development in its final host.

Authors:  Jae-Hwan Kim; Young Ju Kim; Woon-Mok Sohn; Young Mee Bae; Sung-Tae Hong; Min-Ho Choi
Journal:  Parasitol Res       Date:  2009-08-15       Impact factor: 2.289

5.  SUMOylation of paraflagellar rod protein, PFR1, and its stage-specific localization in Trypanosoma cruzi.

Authors:  Takeshi Annoura; Takashi Makiuchi; Idalia Sariego; Takashi Aoki; Takeshi Nara
Journal:  PLoS One       Date:  2012-05-17       Impact factor: 3.240

6.  The Trypanosoma cruzi metacyclic-specific protein Met-III associates with the nucleolus and contains independent amino and carboxyl terminal targeting elements.

Authors:  Eva Gluenz; Martin C Taylor; John M Kelly
Journal:  Int J Parasitol       Date:  2006-12-29       Impact factor: 3.981

7.  Transcriptome Remodeling in Trypanosoma cruzi and Human Cells during Intracellular Infection.

Authors:  Yuan Li; Sheena Shah-Simpson; Kwame Okrah; A Trey Belew; Jungmin Choi; Kacey L Caradonna; Prasad Padmanabhan; David M Ndegwa; M Ramzi Temanni; Héctor Corrada Bravo; Najib M El-Sayed; Barbara A Burleigh
Journal:  PLoS Pathog       Date:  2016-04-05       Impact factor: 6.823

8.  Efficacy of sertraline against Trypanosoma cruzi: an in vitro and in silico study.

Authors:  Daiane Dias Ferreira; Juliana Tonini Mesquita; Thais Alves da Costa Silva; Maiara Maria Romanelli; Denise da Gama Jaen Batista; Cristiane França da Silva; Aline Nefertiti Silva da Gama; Bruno Junior Neves; Cleber Camilo Melo-Filho; Maria de Nazare Correia Soeiro; Carolina Horta Andrade; Andre Gustavo Tempone
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2018-10-30

9.  Unveiling the Differential Antioxidant Activity of Maslinic Acid in Murine Melanoma Cells and in Rat Embryonic Healthy Cells Following Treatment with Hydrogen Peroxide.

Authors:  Khalida Mokhtari; Amalia Pérez-Jiménez; Leticia García-Salguero; José A Lupiáñez; Eva E Rufino-Palomares
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411

10.  Genome-scale metabolic models highlight stage-specific differences in essential metabolic pathways in Trypanosoma cruzi.

Authors:  Isabel S Shiratsubaki; Xin Fang; Rodolpho O O Souza; Bernhard O Palsson; Ariel M Silber; Jair L Siqueira-Neto
Journal:  PLoS Negl Trop Dis       Date:  2020-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.